Skip to main content
. 2022 Oct 28;23(21):13096. doi: 10.3390/ijms232113096

Figure 2.

Figure 2

Treadmill activity duration. */*p < 0.05 compared to the initial value (start of the experiment) (*—DOX; *—NR+DOX). Data are presented as median [25%; 75%]. Control represents control group (n = 15); DOX represents doxorubicin group (n = 15); NR+DOX represents nicotinamide riboside + doxorubicin group—combined mode (n = 15); and NR/NR+DOX represents nicotinamide riboside/nicotinamide riboside + doxorubicin group—preventive mode (n = 15).